No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Acute myeloid leukemia 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: RARA |
D02754 |
Acitretin |
1件: 37 |
2 | Adipocytokine signaling pathway 4 genes, 4 drugs (DrugBank) and 28 diseases shown |
3件: RXRA, RXRB, RXRG |
D02754 |
Acitretin |
1件: 37 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
3 | African trypanosomiasis 3 genes, 4 drugs (DrugBank) and 31 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
4 | AGE-RAGE signaling pathway in diabetic complications 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
5 | Allograft rejection 3 genes, 4 drugs (DrugBank) and 31 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
6 | Alzheimer disease 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
7 | Amoebiasis 5 genes, 5 drugs (DrugBank) and 38 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
8 | Amyotrophic lateral sclerosis (ALS) 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
9 | Antifolate resistance 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
10 | Antigen processing and presentation 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
11 | Apoptosis 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
12 | Asthma 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
13 | Bile secretion 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: RXRA |
D02754 |
Acitretin |
1件: 37 |
14 | C-type lectin receptor signaling pathway 4 genes, 6 drugs (DrugBank) and 31 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
15 | Cell adhesion molecules (CAMs) 2 genes, 2 drugs (DrugBank) and 14 diseases shown |
1件: CD58 |
D02800 |
Alefacept |
6件: 37, 60, 65, 164, 284, 285 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
16 | Chagas disease (American trypanosomiasis) 3 genes, 4 drugs (DrugBank) and 31 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
17 | Cytokine-cytokine receptor interaction 8 genes, 10 drugs (DrugBank) and 39 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL17A |
D10071 |
Ixekizumab |
4件: 37, 162, 269, 271 |
D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
1件: IL17RA |
D10061 |
Brodalumab |
2件: 37, 51 |
2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
18 | Dilated cardiomyopathy (DCM) 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
19 | Endocrine and other factor-regulated calcium reabsorption 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: VDR |
D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
20 | Epstein-Barr virus infection 3 genes, 5 drugs (DrugBank) and 35 diseases shown |
1件: CD58 |
D02800 |
Alefacept |
6件: 37, 60, 65, 164, 284, 285 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
21 | Estrogen signaling pathway 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: RARA |
D02754 |
Acitretin |
1件: 37 |
22 | Fc epsilon RI signaling pathway 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
23 | Fluid shear stress and atherosclerosis 3 genes, 4 drugs (DrugBank) and 36 diseases shown |
2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
24 | Gastric cancer 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: RARB, RXRA, RXRB, RXRG |
D02754 |
Acitretin |
1件: 37 |
25 | Graft-versus-host disease 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
26 | Hematopoietic cell lineage 3 genes, 4 drugs (DrugBank) and 36 diseases shown |
2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
27 | Hepatitis B 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
28 | Hepatitis C 2 genes, 4 drugs (DrugBank) and 28 diseases shown |
1件: RXRA |
D02754 |
Acitretin |
1件: 37 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
29 | Herpes simplex virus 1 infection 3 genes, 4 drugs (DrugBank) and 31 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
30 | Human cytomegalovirus infection 2 genes, 4 drugs (DrugBank) and 36 diseases shown |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
31 | Human immunodeficiency virus 1 infection 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
32 | Human papillomavirus infection 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
33 | Human T-cell leukemia virus 1 infection 4 genes, 5 drugs (DrugBank) and 39 diseases shown |
2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
34 | Hypertrophic cardiomyopathy (HCM) 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
35 | IL-17 signaling pathway 3 genes, 6 drugs (DrugBank) and 30 diseases shown |
1件: IL17A |
D10071 |
Ixekizumab |
4件: 37, 162, 269, 271 |
D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
1件: IL17RA |
D10061 |
Brodalumab |
2件: 37, 51 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
36 | Inflammatory bowel disease (IBD) 5 genes, 8 drugs (DrugBank) and 31 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL17A |
D10071 |
Ixekizumab |
4件: 37, 162, 269, 271 |
D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
37 | Inflammatory mediator regulation of TRP channels 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
38 | Influenza A 3 genes, 4 drugs (DrugBank) and 31 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
39 | Insulin resistance 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
40 | JAK-STAT signaling pathway 3 genes, 3 drugs (DrugBank) and 16 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
41 | Legionellosis 3 genes, 4 drugs (DrugBank) and 31 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
42 | Leishmaniasis 3 genes, 4 drugs (DrugBank) and 31 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
43 | Leukocyte transendothelial migration 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
44 | Malaria 3 genes, 5 drugs (DrugBank) and 33 diseases shown |
1件: IL12A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
45 | MAPK signaling pathway 2 genes, 4 drugs (DrugBank) and 36 diseases shown |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
46 | Measles 2 genes, 1 drug (DrugBank) and 16 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
47 | Mineral absorption 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: VDR |
D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
48 | mTOR signaling pathway 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
49 | Natural killer cell mediated cytotoxicity 2 genes, 4 drugs (DrugBank) and 32 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
50 | Necroptosis 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
51 | NF-kappa B signaling pathway 2 genes, 4 drugs (DrugBank) and 36 diseases shown |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
52 | NOD-like receptor signaling pathway 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
53 | Non-alcoholic fatty liver disease (NAFLD) 2 genes, 4 drugs (DrugBank) and 28 diseases shown |
1件: RXRA |
D02754 |
Acitretin |
1件: 37 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
54 | Non-small cell lung cancer 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: RARB, RXRA, RXRB, RXRG |
D02754 |
Acitretin |
1件: 37 |
55 | Osteoclast differentiation 2 genes, 4 drugs (DrugBank) and 36 diseases shown |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
56 | Parathyroid hormone synthesis, secretion and action 4 genes, 2 drugs (DrugBank) and 8 diseases shown |
3件: RXRA, RXRB, RXRG |
D02754 |
Acitretin |
1件: 37 |
1件: VDR |
D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
57 | Pathogenic Escherichia coli infection 2 genes, 4 drugs (DrugBank) and 36 diseases shown |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
58 | Pathways in cancer 8 genes, 4 drugs (DrugBank) and 16 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
5件: RARA, RARB, RXRA, RXRB, RXRG |
D02754 |
Acitretin |
1件: 37 |
59 | Pertussis 4 genes, 6 drugs (DrugBank) and 31 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
60 | PI3K-Akt signaling pathway 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: RXRA |
D02754 |
Acitretin |
1件: 37 |
61 | PPAR signaling pathway 3 genes, 1 drug (DrugBank) and 1 disease shown |
3件: RXRA, RXRB, RXRG |
D02754 |
Acitretin |
1件: 37 |
62 | Prostate cancer 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
63 | Proteoglycans in cancer 2 genes, 4 drugs (DrugBank) and 31 diseases shown |
1件: IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
64 | Rap1 signaling pathway 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
65 | Regulation of actin cytoskeleton 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
66 | Rheumatoid arthritis 4 genes, 9 drugs (DrugBank) and 33 diseases shown |
1件: IL17A |
D10071 |
Ixekizumab |
4件: 37, 162, 269, 271 |
D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
67 | RIG-I-like receptor signaling pathway 3 genes, 4 drugs (DrugBank) and 31 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
68 | Shigellosis 2 genes, 4 drugs (DrugBank) and 36 diseases shown |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
69 | Small cell lung cancer 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: RARB, RXRA, RXRB, RXRG |
D02754 |
Acitretin |
1件: 37 |
70 | Sphingolipid signaling pathway 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
71 | Staphylococcus aureus infection 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
72 | Systemic lupus erythematosus 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
73 | T cell receptor signaling pathway 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
74 | TGF-beta signaling pathway 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
75 | Th1 and Th2 cell differentiation 2 genes, 1 drug (DrugBank) and 16 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
76 | Th17 cell differentiation 7 genes, 7 drugs (DrugBank) and 25 diseases shown |
1件: IL17A |
D10071 |
Ixekizumab |
4件: 37, 162, 269, 271 |
D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
4件: RARA, RXRA, RXRB, RXRG |
D02754 |
Acitretin |
1件: 37 |
77 | Thyroid cancer 3 genes, 1 drug (DrugBank) and 1 disease shown |
3件: RXRA, RXRB, RXRG |
D02754 |
Acitretin |
1件: 37 |
78 | Thyroid hormone signaling pathway 3 genes, 1 drug (DrugBank) and 1 disease shown |
3件: RXRA, RXRB, RXRG |
D02754 |
Acitretin |
1件: 37 |
79 | TNF signaling pathway 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
80 | Toll-like receptor signaling pathway 3 genes, 4 drugs (DrugBank) and 31 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
81 | Toxoplasmosis 3 genes, 4 drugs (DrugBank) and 31 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
82 | Transcriptional misregulation in cancer 5 genes, 2 drugs (DrugBank) and 17 diseases shown |
1件: IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
4件: RARA, RXRA, RXRB, RXRG |
D02754 |
Acitretin |
1件: 37 |
83 | Tuberculosis 5 genes, 7 drugs (DrugBank) and 35 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
1件: VDR |
D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
84 | Type I diabetes mellitus 3 genes, 4 drugs (DrugBank) and 31 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
85 | Type II diabetes mellitus 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
86 | Viral myocarditis 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
87 | Viral protein interaction with cytokine and cytokine receptor 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
88 | Yersinia infection 1 gene, 3 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |